Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 261
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
V.H. + H-120 - V/NRP/10/0033 PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija QI01AD chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Live Newcastle Disease virus, Infectious Avian bronchitis virus, strain H120
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Synoptis Industrial Sp. z o.o., Polija
Date of authorisation/renewal: 27-Oct-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 231123_LI (23-Nov-2023)
Labelling text: [DOCX] 190920M (19-Sep-2020)
Summary of product characteristics: [DOCX] 190920ZA (19-Sep-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/10/0033-01 10 Stikla flakons, 500 deva -
V/NRP/10/0033-02 10 Stikla flakons, 1000 deva -
V/NRP/10/0033-03 10 Stikla flakons, 2000 deva -
V/NRP/10/0033-04 10 Stikla flakons, 2500 deva -
V/NRP/10/0033-05 10 Stikla flakons, 5000 deva -
Marbocyl P 20mg - V/NRP/03/1572 Vetoquinol S.A., Francija QJ01MA93 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z. o. o., Polija;Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 090710LI (19-Jul-2010)
Labelling text: [DOC] 090710M (19-Jul-2010)
Summary of product characteristics: [PDF] 090710ZA (19-Jul-2010)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1572-01 20 mg 1 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-02 20 mg 2 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-03 20 mg 3 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-04 20 mg 4 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-05 20 mg 5 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-06 20 mg 10 Alumīnija blisteris, 10 tablete -
V/NRP/03/1572-07 20 mg 25 Alumīnija blisteris, 10 tablete -
Tetanusan 50% - V/NRP/09/0006 Kon-Pharma GmbH, Vācija QB05XA30 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Calcium gluconate, Magnesium chloride hexahydrate, Disodium glycerophosphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Kon-Pharma GmbH, Vācija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 26012021LI (26-Jan-2021)
Labelling text: [DOCX] 26012021M (26-Jan-2021)
Summary of product characteristics: [DOCX] 26012021ZA (26-Jan-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/09/0006-01 1 Polipropilēna flakons, 500 ml -
Soligental 3000 IU/ml V/NRP/08/1597 Virbac S.A., Francija QS01AA11 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: eye drops, solution
International name (active substance): Gentamicin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija;Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 01-Jul-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1597-01 3000 IU/ml 1 Flakons, 5 ml -
DEPO-MEDRONE V 40 mg/ml V/NRP/02/1505 Zoetis Belgium S.A., Beļģija QH02AB04 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Methylprednisolone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pfizer Manufacturing Belgium , Beļģija
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1505-01 40 mg/ml 1 Stikla flakons, 5 ml -
Dalmazin 75 µg/ml V/NRP/01/1380 Fatro S.p.A., Itālija QG02AD90 sows; mares; cows Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cloprostenol sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1380-01 75 µg/ml 1 Stikla flakons, 2 ml -
V/NRP/01/1380-02 75 µg/ml 1 Stikla flakons, 10 ml -
V/NRP/01/1380-03 75 µg/ml 1 Stikla flakons, 20 ml -
V/NRP/01/1380-04 75 µg/ml 5 Stikla flakons, 20 ml -
V/NRP/01/1380-05 75 µg/ml 10 Stikla flakons, 10 ml -
V/NRP/01/1380-06 75 µg/ml 15 Stikla flakons, 2 ml -
V/NRP/01/1380-07 75 µg/ml 60 Stikla flakons, 2 ml -
V/NRP/01/1380-08 75 µg/ml 1 Stikla flakons, 50 ml [PDF] [PDF]
V/NRP/01/1380-09 75 µg/ml 1 ABPE flakons, 100 ml -
Sedalin gel 35 mg/ml V/NRP/99/1518 Vetoquinol Biowet Sp. z o.o., Polija QN05AA04 horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: Oral Gel
International name (active substance): Acepromazine (as maleate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z o.o., Polija
Date of authorisation/renewal: 30-Mar-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 210912LI (27-Sep-2012)
Labelling text: [PDF] 210912M (27-Sep-2012)
Summary of product characteristics: [PDF] 210912ZA (27-Sep-2012)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/1518-01 35 mg/ml 1 Šļirce, 10 ml -
Cefalexin Virbac - V/NRP/07/1704 Virbac S.A., Francija QJ51DB01 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 08032022LI (08-Mar-2022)
Labelling text: [PDF] 08032022M (08-Mar-2022)
Summary of product characteristics: [PDF] 08032022ZA (08-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1704-01 375 mg/deva 12 Injektors, 1 deva -
Nobivac RL - V/NRP/96/0379 Intervet International B.V., Nīderlande QI07AL01 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus strain Pasteur RIV, Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 16-Nov-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 280621LI (28-Jun-2021)
Labelling text: [DOCX] 280621M (28-Jun-2021)
Summary of product characteristics: [DOCX] 280621ZA (28-Jun-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0379-01 10 Stikla flakons (kartona kastē), 1 deva -
V/NRP/96/0379-03 10 Stikla flakons (plastmasas kastē), 1 deva -
Orbenin EDC 600 mg V/NRP/99/0980 Zoetis Belgium S.A., Beļģija QJ51CF02 cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cloxacillin benzathine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 30-Oct-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/0980-01 600 mg 24 Injektors, 1 deva -
V/NRP/99/0980-03 600 mg 120 Injektors, 1 deva -
V/NRP/99/0980-04 600 mg 200 Injektors, 1 deva -
V/NRP/99/0980-05 600 mg 1 Injektors, 1 deva -
LV Introvit-B-Complex - V/NRP/12/0042 Interchemie Werken De Adelaar Eesti AS, Igaunija QA11EA cattle; pigs; sheep; goats; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Biotin,Dexpanthenol,Pyridoxine hydrochloride,Riboflavine sodium phosphate,Thiamine hydrochloride,Nicotinamide,Choline chloride,Cyanocobalamin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 290617LI (04-Jul-2017)
Labelling text: [PDF] 290617M (04-Jul-2017)
Summary of product characteristics: [PDF] 290617ZA (04-Jul-2017)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/12/0042-01 1 Stikla flakons, 100 ml -
LV Biocillin-500 WS 500 mg/ml V/NRP/18/0027 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01CA04 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: powder for use in drinking water
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 290318LI (05-Apr-2018)
Labelling text: [PDF] 290318M (05-Apr-2018)
Summary of product characteristics: [PDF] 290318ZA (05-Apr-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/18/0027-01 1 Alumīnija folijas maisiņš, 100 g -
V/NRP/18/0027-02 1 ABPE pudele, 1000 g -
LV Biocillin-150 LA 150 mg/ml V/NRP/11/0063 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01CA04 cattle; pigs; sheep; goats; calves Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 281116LI (30-Nov-2016)
Labelling text: [PDF] 281116M (30-Nov-2016)
Summary of product characteristics: [PDF] 281116ZA (30-Nov-2016)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/11/0063-01 150 mg/ml 1 Stikla pudele, 100 ml -
LV Macrolan 200 mg/ml V/NRP/14/0064 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01FA90 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tylosin tartrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jun-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 240120LI (24-Jan-2020)
Labelling text: [PDF] 240120M (24-Jan-2020)
Summary of product characteristics: [PDF] 240120ZA (24-Jan-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/14/0064-01 200 mg/ml 1 Stikla pudele (brūna), 100 ml -
Indigest injectable 100 mg/ml V/NRP/01/1294 Laboratorios Calier, S.A., Spānija QA05AX90 cattle; pigs; sheep; goats; horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Menbutone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratories Calier S.A., Spānija
Date of authorisation/renewal: 21-May-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (25-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1294-02 100 mg/ml 1 Flakons, 100 ml -
Biofel PCHR - V/NRP/17/0006 Bioveta, a.s., Čehija QI06AA09 cats Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated feline panleucopenia virus, strain FPV Bio 7,Inactivated feline calicivirus, strain FCV F9 Bio-8,Inactivated feline herpes virus, strain FHV 1 Bio-9,Inactivated rabies virus, strain Vnukovo Bio-16
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 20-Dec-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 211221LI (21-Dec-2021)
Labelling text: [DOCX] 211221M (21-Dec-2021)
Summary of product characteristics: [DOC] 211221ZA (21-Dec-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/17/0006-01 2 Stikla flakons, 1 deva -
V/NRP/17/0006-02 10 Stikla flakons, 1 deva -
V/NRP/17/0006-03 5 Stikla flakons, 5 deva -
V/NRP/17/0006-04 10 Stikla flakons, 5 deva -
V/NRP/17/0006-05 20 Stikla flakons, 1 deva -
V/NRP/17/0006-06 100 Stikla flakons, 1 deva -
V/NRP/17/0006-07 1 Stikla flakons, 5 deva -
Phenocoat 5 mg V/DCP/25/0012 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0012-01 1 Blisteris, 10 tablete -
V/DCP/25/0012-02 2 Blisteris, 10 tablete -
V/DCP/25/0012-03 3 Blisteris, 10 tablete -
V/DCP/25/0012-04 4 Blisteris, 10 tablete -
V/DCP/25/0012-05 5 Blisteris, 10 tablete -
V/DCP/25/0012-06 6 Blisteris, 10 tablete -
V/DCP/25/0012-07 7 Blisteris, 10 tablete -
V/DCP/25/0012-08 8 Blisteris, 10 tablete -
V/DCP/25/0012-09 9 Blisteris, 10 tablete -
V/DCP/25/0012-10 10 Blisteris, 10 tablete -
V/DCP/25/0012-11 25 Blisteris, 10 tablete -
Phenocoat 12.5 mg V/DCP/25/0013 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0013-01 1 Blisteris, 10 tablete -
V/DCP/25/0013-02 2 Blisteris, 10 tablete -
V/DCP/25/0013-03 3 Blisteris, 10 tablete -
V/DCP/25/0013-04 4 Blisteris, 10 tablete -
V/DCP/25/0013-05 5 Blisteris, 10 tablete -
V/DCP/25/0013-06 6 Blisteris, 10 tablete -
V/DCP/25/0013-07 7 Blisteris, 10 tablete -
V/DCP/25/0013-08 8 Blisteris, 10 tablete -
V/DCP/25/0013-09 9 Blisteris, 10 tablete -
V/DCP/25/0013-10 10 Blisteris, 10 tablete -
V/DCP/25/0013-11 25 Blisteris, 10 tablete -
Phenocoat 25 mg V/DCP/25/0014 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0014-01 1 Blisteris, 10 tablete -
V/DCP/25/0014-02 2 Blisteris, 10 tablete -
V/DCP/25/0014-03 3 Blisteris, 10 tablete -
V/DCP/25/0014-04 4 Blisteris, 10 tablete -
V/DCP/25/0014-05 5 Blisteris, 10 tablete -
V/DCP/25/0014-06 6 Blisteris, 10 tablete -
V/DCP/25/0014-07 7 Blisteris, 10 tablete -
V/DCP/25/0014-08 8 Blisteris, 10 tablete -
V/DCP/25/0014-09 9 Blisteris, 10 tablete -
V/DCP/25/0014-10 10 Blisteris, 10 tablete -
V/DCP/25/0014-11 25 Blisteris, 10 tablete -
Phenocoat 50 mg V/DCP/25/0015 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0015-01 1 Blisteris, 10 tablete -
V/DCP/25/0015-02 2 Blisteris, 10 tablete -
V/DCP/25/0015-03 3 Blisteris, 10 tablete -
V/DCP/25/0015-04 4 Blisteris, 10 tablete -
V/DCP/25/0015-05 5 Blisteris, 10 tablete -
V/DCP/25/0015-06 6 Blisteris, 10 tablete -
V/DCP/25/0015-07 7 Blisteris, 10 tablete -
V/DCP/25/0015-08 8 Blisteris, 10 tablete -
V/DCP/25/0015-09 9 Blisteris, 10 tablete -
V/DCP/25/0015-10 10 Blisteris, 10 tablete -
V/DCP/25/0015-11 25 Blisteris, 10 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy